Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group. Zoungas S, et al. Among authors: cooper me. N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19. N Engl J Med. 2014. PMID: 25234206 Free article. Clinical Trial.
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon S, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S; ADVANCE Collaborative Group. Perkovic V, et al. Among authors: cooper me. Kidney Int. 2013 Mar;83(3):517-23. doi: 10.1038/ki.2012.401. Epub 2013 Jan 9. Kidney Int. 2013. PMID: 23302714 Free article. Clinical Trial.
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, MacMahon S, Mancia G, Marre M, Matthews D, Neal B, Poulter N, Rodgers A, Williams B, Zoungas S; ADVANCE-ON Collaborative Group. Wong MG, et al. Among authors: cooper me. Diabetes Care. 2016 May;39(5):694-700. doi: 10.2337/dc15-2322. Epub 2016 Mar 22. Diabetes Care. 2016. PMID: 27006512 Free article. Clinical Trial.
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
van Steen SC, Woodward M, Chalmers J, Li Q, Marre M, Cooper ME, Hamet P, Mancia G, Colagiuri S, Williams B, Grobbee DE, DeVries JH; ADVANCE Collaborative Group. van Steen SC, et al. Among authors: cooper me. Diabetologia. 2018 Apr;61(4):780-789. doi: 10.1007/s00125-017-4539-1. Epub 2018 Jan 8. Diabetologia. 2018. PMID: 29308539 Free PMC article. Clinical Trial.
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Selvin E, Wang D, McEvoy JW, Juraschek SP, Lazo M, Hamet P, Cooper ME, Marre M, Williams B, Harrap S, Chalmers J, Woodward M. Selvin E, et al. Among authors: cooper me. Diabetes Obes Metab. 2019 Aug;21(8):2017-2023. doi: 10.1111/dom.13755. Epub 2019 May 29. Diabetes Obes Metab. 2019. PMID: 31050156 Free PMC article. Clinical Trial.
UKPDS and the legacy effect.
Chalmers J, Cooper ME. Chalmers J, et al. Among authors: cooper me. N Engl J Med. 2008 Oct 9;359(15):1618-20. doi: 10.1056/NEJMe0807625. N Engl J Med. 2008. PMID: 18843126 No abstract available.
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
van Dieren S, Kengne AP, Chalmers J, Beulens JW, Cooper ME, Grobbee DE, Harrap S, Mancia G, Neal B, Patel A, Poulter N, van der Schouw YT, Woodward M, Zoungas S. van Dieren S, et al. Among authors: cooper me. Diabetes Res Clin Pract. 2012 Oct;98(1):83-90. doi: 10.1016/j.diabres.2012.05.002. Epub 2012 Jun 5. Diabetes Res Clin Pract. 2012. PMID: 22677192 Free article. Clinical Trial.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative group. Zoungas S, et al. Among authors: cooper me. Diabetologia. 2014 Dec;57(12):2465-74. doi: 10.1007/s00125-014-3369-7. Epub 2014 Sep 17. Diabetologia. 2014. PMID: 25226881 Clinical Trial.
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group. Ohkuma T, et al. Among authors: cooper me. Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060. Hypertension. 2019. PMID: 30571562 Free article. Clinical Trial.
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
Kim H, Wang D, Chalmers J, Jun M, Zoungas S, Marre M, Hamet P, Harrap S, Mancia G, Poulter NR, Cooper ME, Woodward M, Selvin E, Rebholz CM. Kim H, et al. Among authors: cooper me. J Diabetes. 2020 Dec;12(12):929-941. doi: 10.1111/1753-0407.13083. Epub 2020 Jul 27. J Diabetes. 2020. PMID: 32609422 Free PMC article. Clinical Trial.
708 results